A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors
A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors
Active, not recruiting · NCT07387874 · Registry updated 2026-02-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Active, not recruiting | Not stated | 2026-02-04 | NCT07387874 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lixiaoling | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BeidahuangGGH | Harbin | China | 1 |